Cowen analyst Boris Peaker reiterated an Outperform rating on POINT Biopharma Global Inc. (NASDAQ: PNT) and named the stock a ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE